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Information and support needs of patients with High Grade Gliomas
Abstract
Objective: To understand patients' experiences of High Grade Glioma and identify and describe 
information and support needs along the disease trajectory.
Methods: Semi-structured interviews were conducted with nineteen patients. Data was analysed 
using grounded theory and the constant comparative method.
Results: Four major themes were identified: 1) feelings of uncertainty around prognosis and 
quality of life; 2) the need for individualised information; 3) dependence on carers due to 
cognitive deficits, loss of balance and inability to drive; and 4) communication with health 
professionals around prognostic uncertainty and disease progression with communication barriers
due to complex language deficits.
Conclusion: Previous studies in HGG pre-date the current combined modality standard of care, 
or examined a mixed population. This study has found that patients with HGG have needs that 
differ from other patients with terminal malignancy and that these needs change over time with 
disease progression. 
Practice Implications: This study has identified that patients with brain tumours may have 
unique needs. Health professionals need to clarify patients’ information and support needs and be 
aware that these change over and within time.
Keywords: High grade glioma, patient perspective, information and support needs, oncology. 
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1. Introduction
Malignant High Grade Gliomas (HGG) represent approximately 80% of primary brain tumours in 
adults and are usually fatal, with median survival ranging from 1 to 3 years from diagnosis [1, 2].  
Current treatments involve combinations of surgical resection, chemotherapy and radiation 
therapy, taking about eight months for the primary treatment course [3, 4]. Suitable patients may 
receive further surgery, stereotactic radiotherapy, or second-line chemotherapy before dying from 
their disease.
1.1 Specific needs of patients with High Grade Gliomas
Unlike patients with other terminal cancer diagnoses patients with HGG are more likely to have 
physical or cognitive deficits from the time of diagnosis. For example, memory or speech loss,
seizures, lack of balance and visual deficits can impact on their lives from early in the disease 
trajectory [5]. Loss of independence occurs not only because of physical or cognitive deficits, 
but because patients can no longer legally drive a motor vehicle, or because carers are reluctant to 
leave them alone for fear of seizures.  Ongoing palliative treatment with corticosteroids can lead 
to weight gain, mood swings and personality changes. Furthermore, in HGG the prognosis is 
often uncertain, leading to difficulty in doctor-patient communication.
Common presenting features include cognitive decline, headaches, seizures, and motor deficits
[5]. Similarly to other cancer patients, once diagnosed, individuals need to deal with many 
confronting emotions and make complex treatment decisions.  However, more particular to the
HGG patients is the need to adjust their lifestyles to accommodate the functional, emotional or 
cognitive decline that is a feature of this disease.  Such decline is often associated with inability 
to work or participate in previously productive activities [2, 6]. Hence, this diagnosis tends to 
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have a profound impact on the individual’s quality of life and as a result it is likely that these 
patients have psychosocial needs that differ to those of other cancer patients. 
Previous qualitative studies have supported this contention; however, these reports either pre-date 
the current combined modality standard of care [3], or examined a mixed population of high and 
low grade glioma patients. 
An Australian study examined 18 patient/carer dyads recruited through a brain tumour support 
service; however, only 11% of patients had HGG and the study pre-dated current standard 
therapy.  The following themes emerged: “a need for information and strategies for coping with 
uncertainty, practical support, support to return to pre-treatment responsibilities or prepare for 
long-term care, support to deal with social isolation and organise respite care, support to 
overcome stigma/discrimination and support to discuss potentially reduced life expectancy”[7, p. 
1]. Other studies have found that depression and anxiety are common and are associated with 
lack of motivation; bodily deterioration; finances; cognition; physical appearance; and marital 
difficulties [8]. A peri-operative study in Finland described 8 patients’ experiences of having a 
brain tumour and their perceptions of the care that they received using peri-operative interviews. 
Patients highlighted the importance of receiving treatment and prognostic information, and
wanted more opportunities to discuss their illness with other people [9].
Building on these studies, Davies and Higginson [10] published a systematic review on the 
communication, information and support needs of patients diagnosed with HGG. Twelve 
observational studies were found for the period until 2000. This review concluded that patients 
require tailored information and support. A second review was conducted by Catt et al. [11] for 
the period from 2000 to 2007. Both reviews concluded that additional research in this area was 
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needed, in order to develop and assess psychosocial and supportive interventions to meet 
patients’ information and support needs and to educate staff caring for these patients.     
In Australia, temozolomide has been available for adjuvant use in grade IV HGG since 2005. 
While there have been previous studies exploring the needs of HGG patients, such studies have 
not been reported in an Australian population, or since the advent of a new standard of care 
including chemoradiotherapy and subsequent adjuvant chemotherapy. In order to develop 
appropriate psychosocial interventions, we first need a detailed understanding of the needs of 
patients at various points along the disease trajectory. Therefore, the aims of this study were to:
(1) gain an understanding of patients’ experiences of living with HGG and (2) identify and 
describe the information and support needs of these patients.
1.2 Theoretical Framework
The theoretical framework that informed this study was Maslow’s hierarchy of needs[12],
recently adapted to palliative care by Zalenski and Raspa [13].  The five levels of need as 
described by Zalenski and Raspa  are: (1) managing distressing symptoms; (2) fears for physical 
safety, of dying or abandonment; (3) affection, love and acceptance; (4) esteem and respect and 
(5) self actualisation and transcendence[13]. HGG patients are likely to have similar needs and 
may need to work through lower level needs before they can move forward and live with their 
disease. This theoretical framework will be used to understand the different needs that patients 
describe.        
2. Method
The study was approved by relevant Human Research Ethics Committees. 
2.1 Participants:   
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Eligible patients were: within one year of diagnosis of Grade III-IV HGG, 18 years of age or 
older, able to participate in interviews, and conversant in English. Patients were excluded if they 
had a non-primary brain tumour, or cognitive impairment as reported by the clinician or carer. 
2.2 Recruitment:
Patients were recruited through the medical oncology department of a tertiary referral 
centre for neurological cancers. Acknowledging the difficulty in recruiting patients with 
brain cancer, we attempted to capture patients at different stages of their disease process 
(e.g. during chemo-radiotherapy, adjuvant chemotherapy or at disease recurrence) and 
with differing socio demographic features.  The clinician involved offered participation to 
consecutive patients until a  variety of clinical and social situations were represented; 
recruitment then became purposive to ensure that patients with under-represented clinical 
or social settings were able to be included in the study. The social situations we focused on 
were: young versus mature patients, patients with dependent children versus children who 
have left home or no children, patients living alone versus patients with carers, female 
patients versus male patients and patients living in metropolitan locations versus rural 
locations.  Within the disease limitations of physical and cognitive impairment we continued 
the interviews until no new data emerged.
Patients were initially identified as eligible for the study by their treating clinician. If eligible, the 
treating clinician provided the patients and carers with an information sheet about the study and 
requested their permission to provide their contact details to the research officer. The research 
officer then contacted the participants to explain more about the study and organize a time to 
meet and conduct the interviews. Prior to commencing the interview the research officer provided 
additional information about the study and obtained written informed consent.  
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2.3  The interview
One semi-structured interview was conducted with each participant to gain an understanding of 
patients’ experiences and determine their needs as they progress through treatment. The interview 
guide is provided in Figure 1. All interviews were conducted by health professionals who had 
experience in conducting semi-structured interviews for research purposes. Face-to-face 
interviews were conducted where possible (in the patient’s home or another convenient location), 
otherwise interviews were conducted via telephone (n=1 patient). Patients were asked about their 
cancer experience and the difficulties they have faced, and their information, support and 
practical needs during their illness. Prompt questions were used when required. 
Where possible, the carer was interviewed first and alone. After this interview was 
complete the patient was invited to participate. The interviewer did request that they 
conduct the interviews separately, however, in some cases the carer choose to remain and in 
these situations the researchers did not think it was appropriate to ask the carers to leave. 
In some cases the carer stayed out of concern for the patient (whether this was concerns 
over the patient’s physical or emotional state we could not determine).  The patient’s 
decision to participate in the interview was individual, therefore if a patient decided they 
were fit enough to participate and signed the consent form they were interviewed. 
Interviews with patients lasted between 30 and 90 minutes. Carers who remained with the 
patients during these interviews acted as informants for the patients and added to the richness of 
the data. Interview questions/prompts were amended slightly as data analysis continued and we 
began to understand the needs of the patients and the areas where we required further 
information. The researchers remained open during the interviews and gave the participants many 
opportunities to describe their own individual concerns as well as respond to interview questions 
8
that were asked. The researchers were also flexible in terms of the interview structure. For 
example, if a patient started discussing their support needs first, the researcher discussed these 
issues and then moved on to talk about information needs. 
Insert Figure 1 here
2.4 Data Analysis
Interviews were tape recorded and transcribed verbatim. Data analysis was iterative and 
commenced after the first interview. The analysis took place concurrently with data collection 
and was used to suggest additional questions/prompts in subsequent interviews to ensure 
divergent points of view would be expressed [14].
Data analysis was conducted using grounded theory and the constant comparative method [15]. 
Transcripts were loaded into the software program QSR NVivo, Version 7 (2006). Open, axial 
and selective coding was used to analyse the data [15]. Open coding involved repeated reading of 
the sections of the interviews relating to the patient’s needs and a line-by-line analysis of this 
data. Axial coding was used to link data and determine the mechanisms that existed. Selective 
coding was then used to link data together and develop the themes. Interpretation of the themes 
and data collected was then informed by Maslow’s hierarchy of needs as described above [12].
3. Results
Thirty patients with HGG were invited to participate. Six declined due to deteriorating health, 
four refused and one died before the scheduled interview, leaving 19 participants. The mean age 
was 55 years (range 31 to 74, SD = 10). Table 1 summarises the patient characteristics. All 
patients had, or were having, treatment with seven weeks combined chemo-radiotherapy using 
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temozolomide and a further six months of temozolomide chemotherapy; however, some patients’
disease progressed during treatment or were unable to tolerate treatment, leading to cessation of 
therapy or second-line treatment.
Insert Table 1 here
Four overriding themes emerged: feelings of uncertainty; the need for information; dependence 
on their carer and communication with health professionals. Each of these themes was comprised 
of interrelated sub-themes that related specifically to the diagnosis of HGG. It was evident that 
throughout the experience of HGG patients were re-evaluating their futures and what would 
happen to them as their disease progressed. Figure 1 provides a diagrammatic representation of 
the themes and sub-themes relating to HGG.
Insert Figure 2 here
3.1 Feelings of uncertainty
At the point of receiving the diagnosis everything was unfamiliar and uncertain for HGG 
patients. The main areas that patients were uncertain about included their prognosis and future, 
the effect the diagnosis would have on their quality of life and treatment side effects. 
  
3.1.1 Uncertainty about prognosis 
Patients highlighted the feature of an unclear prognosis in HGG:
“We still don’t know what we’re going to have to look forward to in the future because, you 
know when you do ask you still get a little bit of a vague answer…” Patient011 
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“It’s like you’ve hit a brick wall… it’s not like it’s sponge foam and you can tear it apart 
and go through it.  It’s been a brick wall and it’s been a fight to me, devastating, hit this 
brick wall and sort of knowing, but not knowing what’s on the other side.”  Patient017
These two exemplars demonstrate that receiving an unclear prognoses was frustrating for patients 
because they did not know what to expect in the future and therefore could no longer plan their 
lives. The following sub-themes further demonstrate the uncertainty experienced by patients. 
Uncertainty about how the diagnosis would affect their quality of life 
Patients not only experienced uncertainty in relation to their prognosis, but also in relation to how 
their diagnosis and the symptoms they would experience would impact on their quality of life. 
Patients reported that they were particularly concerned that they would experience a stroke or 
seizure: 
“Like I want to know, would I have a stroke or would the symptoms just come back 
because the tumour was just growing back… you know I wanted to know what was going 
to happen to me, would I have a seizure, because I wanted to tell my children, what to do 
if they’re home alone with me and something happens.”  Patient014 
As this exemplar demonstrates, patients were not only concerned about how their condition 
would affect their own lives, they were also concerned about the impact that their condition 
would have on their family members and friends. 
3.1.2 Uncertainty about the side effects of treatment 
The period after surgery was a particularly uncertain time for patients, as this exemplar 
illustrates:
“If you think about what part of your body you don’t want surgery on it’s your brain 
and you know that’s what I ended up having.  The question is OK you come out of it, 
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you’ve gotta have this operation, you’ve got a surgeon that you know is a good 
surgeon, that’s great. But at the end of the day you find out what your new condition 
is like when you wake up and, am I going to be able to speak, am I going to be able to 
move my arms and legs, am I going to be able to swallow, and I going to be able to do 
these things…”  Patient007
Although this patient was informed about the side effects of surgery they reported that they felt 
unsure about how they would recover and were concerned that surgery might affect their physical 
abilities. 
Patients experienced uncertainty about treatment decisions, post-operative recovery and adjuvant 
treatments and what would happen as the disease progressed. Patients were particularly 
concerned about seizures, vision loss, memory loss, speech difficulties and lack of mobility. They 
also expressed uncertainty about their ability to return to work, financial stability and resumption 
of previous activities.  
3.2 The need for information
Patients had varying information needs over disease progression and symptomatic deterioration.
Patients discussed the need for different sources of information and variety in the way that 
information is provided. While some preferred written information, others highlighted the 
importance of verbal repetition and access to health care professionals (e.g. the Neuro-oncology 
Cancer Nurse Coordinator) for specific information. The following sub-themes related 
specifically to HGG: the need for information relating to prognosis and the need for information 
to be provided using different types of medium. 
3.2.1 The need for information relating to prognosis
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Patients expressed concern about delays in receiving prognostic information, and the 
uncertainties of such information. One patient explained their need for information while 
awaiting a confirmed histopathological diagnosis: 
“I never got really good confirmation of my condition… They thought it was the bad one; 
which I worked with in my own head until eventually and it’s quite right they’ve got to do 
it until they get confirmation it’s such a long winded thing. …over a week to get a biopsy 
confirmed. And a week is a long time to hover around - thinking ... and that was after 
having all the, up to the operation, having the operation and then the thing gets sent away 
another week. After that you get told that you have got whatever it is and then, then you 
get the right information.” Patient004 
This patient wanted information as soon as they received an initial diagnosis of brain cancer. 
They found it difficult to wait for their diagnosis. However, once they received their diagnosis 
they reported that adequate information was provided to meet their needs. Other patients 
similarly reported that they found this waiting period difficult because they wanted additional 
information to be provided. 
3.2.2 The need for information to be provided using different types of medium
Some patients desired more specific written information about HGG:
“I was just looking at trying to find something to read and I couldn’t find anything about 
brain cancer or anything like that.”  Patient014
However, other patients expressed a specific need for verbal information because they had 
difficulty with their vision, or processing written information: 
“I’ve got a loss of little peripheral vision he thinks…” Patient017 
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“I’m not very good at reading. I want them to tell me.” Patient001
It was essential that health professionals were aware of the patient’s individual needs and tailored 
the way they provided information. Information needs to be presented in a way that is relevant to 
the patients as this quote illustrates: 
“The nurse just gave me a book and she said “read about brain tumours” don’t do this 
and don’t do that, don’t wash your hair, don’t blow dry your hair, but you know it’s not 
enough.  I want to know why you don’t do this.” Patient001
Continuity in the provision of information was also highlighted:
“Well, everybody else seems to know what they stand…I think what happened was the 
doctor who was in charge retired and they put somebody in charge and then they think he 
told me but he didn’t.” Patient 001
3.3 Dependence on their carer
Patients’ physical and psychological integrity changed as their disease progressed; the following 
exemplars demonstrate that patients felt unable to fill their previous roles, became more 
dependent on their carers, and varied in their acceptance of this dependency:
“I just left everything up to her…I mean I’m totally dependent on her.” Patient010
The patient’s carer was present in this interview and similarly reported that she needed to care for 
him and make decisions for him. 
While some patients were grateful for such support:
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“It takes a load off my mind to have that person right next to you that you can trust and 
love and looking after things for you. It just means so much… couldn’t do it without them, 
as a helper, no way you could not do it.  ” Patient013 
The patient’s carer was also present in this interview. Patient 013 reported that they felt that they 
could not manage all of the physical tasks required and therefore needed to rely on their carer to
assist them. They also indicated that they would need to rely on their carer further in the future.
Others struggled with a loss of independence:
“She’s a little bit probably too much at times…you know “Are you cold”, “Can I get you a 
rug” … I’m not dead yet.  So, yeah, just a little bit over the top with some of that sort of 
stuff.”   Patient019 
This patient’s carer was not present at the interview. 
Another patient similarly described how he was struggling with a loss of independence:
“I get heaps of support from them, but its sympathy which I don’t want. Since this started 
(wife) hasn’t cooked a meal, I’ve cooked all the meals, I’m not going let her carry on and 
I hate sympathy.” Patient 004
3.3.1 Managing weight gain 
Many patients were conscious of the need to monitor weight gain, resulting from corticosteroids: 
“If you didn’t have some work activities by gosh you’d be blown out and I mean I would 
have eaten anything…now you just force yourself to eat fruits and dried biscuits and the 
nice sweet biscuits and all those sorts of things.”  Patient017
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Other patients similarly reported that they were concerned about managing weight gain and the 
role that their carers had in ensuring that they ate properly. 
“There is only one (handle) bar on the bath. I knew I would be able to get in, but I always 
thought, knew with my weight, the way it’s blossomed, mushroom, whatever you’d like to 
say, that I would have trouble getting out…I left the door unlocked so if I needed help, my 
husband would have had to come, I don’t know how he would have done it, pulled me 
out.”  Patient015
“They give you a steroid to shrink the tumour and you loose control of your appetite so 
you just want to eat sort of 24 hours a day, you just feel like eating and so you have to 
control that otherwise you just blow up like a balloon and then they dump anti-nausea 
drugs on you so you can cope with the chemo and that slowed down my metabolism down 
again so I not only ate, it just didn’t go anywhere.” Patient 004
3.3.2 Managing medication
Patients were also dependent on their carers to manage complex medication regimes including 
intermittent, home-administered chemotherapy and anti-emetics, anticonvulsants and 
corticosteroids: 
“My husband does it all… That’s what I say to him, “Thank goodness I’m not doing all 
this, because, Oh God I could give myself anything.” It’s wonderful that he does it all for 
me.” Patient011
Other patients similarly reported the difficultly they had in managing their medications. Carers 
played an essential role in being informed about medications and ensuring appropriate 
medication management. 
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3.3.3 Loss of balance
HGG patients became physically reliant on carers because of loss of balance and lost physical 
function: 
“Yeah, I’ve got to sit here all day, listen to the radio and watch television, I can’t do 
anything at all (tearful mumbling), it’s affected all my balance, my nerves in my arms and 
my legs and I just can’t do anything, it’s very upsetting…” Patient001 
HGG had an impact on the patient’s whole lives. It was particularly distressing for them when 
they lost their physical ability because this limited them so much and indicated that they had lost 
their independence. 
3.3.4 Inability to drive
A brain tumour diagnosis has legal implications for driving, and many patients were dependent 
on others for transport to appointments and social events. One rural patient explained how he had 
become dependent on his wife to drive, which was difficult because she was uncomfortable 
driving in the city:
“You know we have got a driving issue. We are from the country and suddenly I cannot 
drive and I have got a wife and who has only driven in a country town, driving in the 
main streets of the city and it is just chaotic.  So I’m having to try to say: “You do not do 
that” and we’ve driven home in tears and the pattern is almost everyday.”  Patient004
This loss was associated with a loss of control, increased reliance on others, and inability to
function independently:
“It is frustrating having to rely on other people to be able to get to places.”  Patient014
3.4 Communication with health professionals
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Both patients and carers needed to communicate with the health professionals to ensure that their
information needs were met. Health professionals were seen to be able to provide expert opinion, 
treatment and support. 
3.4.1 Involvement in decision-making
Health professionals tried to include patients in decision-making and address their information 
needs. However, as this patient explained they found it difficult to be actively involved in the 
decision-making process:  
“I think I’ve been involved with it (decision-making) but at the end of the day it’s like, 
we’ve got this choice of doing this or not; like well at the end of the day it’s your 
decision. It’s one of those things where you do have a decision but at the end of the 
day you really don’t.” Patient007
Decision-making was difficult for patients because there was prognostic uncertainty. 
Although health professionals tried to include them in the decision-making process, they did 
not feel they really had treatment alternatives. Patients tried to gather the information that 
they required during consultations where decisions needed to be made. As demonstrated in 
the previous theme, patients relied on their carers to gather information and take 
responsibility for their treatment decision-making.  
3.4.2 Opportunities to communicate and ask questions
Although patients were often not actively involved in decision-making they appreciated the 
opportunity to gain information and ask questions from medical staff: 
“They had a family consultation which I knocked back and made an individual 
consultation and got down to the nitty gritty straight away and I wanted to know what it 
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was all about… They told me what would happen eventually when the inevitable happens.  
They were real up front…The doctor spent nearly an hour and a half answering every 
question that I had.” Patient004
This patient lives in a rural location and was interviewed separately from their carer. This patient 
reported that they felt it was important to be informed as much as possible so that they could try 
to prepare themselves for what was going to happen in the future.
3.4.3 Difficulties with communicating effectively
Although patients reported that they were satisfied with their communication with their doctor, 
cognitive and memory deficits hampered effective communication with health professionals. One 
patient recalled: 
“Now whether that was related to my memory retention I don’t know. I sometimes wonder 
if people said something to me and I just didn’t remember it or whether I didn’t want to 
hear it so I blocked it.” Patient023
Some patients were unable to participate because they were unable to communicate effectively
due to expressive dysphasia. Carers of these patients therefore acted as surrogate patients and 
provided both perspectives. The carer explained how difficult it was for their partner to 
communicate effectively:  
“Cause my husband really can’t make himself understood at times and other times he 
can.  But it’s very frustrating when he can’t speak and use words, and he puts in all the 
wrong words … Very frustrating and he also finds that humiliating because it’s quite 
indecipherable when he does that.” Carer024
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As these exemplars demonstrate, the patient’s ability to obtain information and support was 
sometimes affected by communication deficits.  Therefore, carers were often involved in 
communicating with health professionals and participated in decision-making on behalf of the 
patients. 
The timing of information provision was also raised by many of those interviewed, particularly 
around the time of diagnosis, as this exemplar illustrates:
“ And the first I knew about all of this sort of woke up in the bed in hospital and Dr 
(name) introduced himself and straight away there was a whole group of other doctors.  
He straight away said to me I’m very sorry to tell you but you’ve only got two months to 
live.  I was shocked, I was shocked.” Patient015
4. Discussion and Conclusion
4.1 Discussion
This study addresses a need for research focusing on patients with HGG. As identified by Catt et 
al. [11], further research is required to first understand these patient’s needs and secondly develop 
and assess psychosocial and supportive interventions. 
The main themes that emerged were: feelings of uncertainty; the need for information; 
dependence on their carer and communication with health professionals. Throughout the patients’ 
experience of HGG they continued to re-evaluate their futures. Although each of the main themes 
can be related to all cancer diagnoses, the sub-themes presented in Figure 2 and throughout the 
results demonstrate the specific needs of HGG patients.  
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Consistent with previous research [9], patients in this study were shocked by their diagnosis and 
experienced fear and anxiety. Unlike patients with early stage cancer, these people made a 
sudden transition to being a patient with an uncertain prognosis, often with permanent intellectual 
and physical deficits which impacted on their lifestyle immediately. Patients with brain tumours 
may experience a sub-acute but substantial decline in function over the illness. In contrast, many 
other patients with metastatic non-brain cancers can experience periods of continued good 
cognitive and physical function, with a rapid functional decline in the terminal phases of the 
illness. 
Patients experienced uncertainty about many aspects including treatment options, prognosis, 
symptoms and side effects and how they could cope with the changes that were occurring. 
Uncertainty is defined by Penrod [16] as ‘a state that people experience, where they are unable to 
assign probabilities to what is going to happen in the future’. This feeling of uncertainty 
continued throughout the patients’ experience of HGG because they were unable to assign 
probabilities to how long they would live or what would happen to them.    
Patients needed information about their diagnosis and prognosis. Lepola et al. [9] and Janda et al. 
[7] similarly reported that brain cancer patients placed high importance on prognostic 
information. However, the timing of such information was often questioned, particularly when 
the “bad news” was delivered immediately after surgery when they were recovering and often not 
in a position to take in the information. Patients in our study also highlighted the uncertainty they 
faced around their prognosis, as indeed, even the doctors could not predict when or how rapidly 
their physical or cognitive decline may occur.  They were uncertain about potential consequences 
of their illness such as loss of independence, seizures, weight gain, diet,  loss of mobility, 
inability to drive and how HGG would impact on their quality of life. 
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Patients required verbal and written information about treatment, support services, and what 
happened as the disease progressed. However, again, timing was an issue as many patients were 
“not ready” to discuss palliative care services or the introduction of support services into the 
home.  This was perceived as generating a “loss of hope”. Patients valued the presence of a carer 
when receiving information, particularly if they had cognitive impairment. For the same reason, 
information needs to be framed simply and positively. 
This study has illustrated that the provision of information is not a simple task for the clinician.  
Some of the patients interviewed wanted their doctor to “tell it like it is”, while others only 
wanted to know positive information, or minimum information.  Some patients reported that they 
searched the internet for information, while others did not want to know.  This highlights the 
importance of clinicians informing patients of the type of information they can provide and 
eliciting how much information the patient required [17]. There is evidence that patient’s 
information and decision making preferences change over time [18]. This was highlighted in our
study, where patient’s needs varied not only because of their disease status or cognitive decline, 
but often because patients moved from wanting to know and then not wanting to know. This is 
challenging for clinicians, however; as the communication guidelines highlight, the importance 
of individualising information and eliciting concerns is vital to the communication process [17].
HGG patients became increasingly dependent on their carers as they progressively lost physical 
and/or intellectual functions. This paper expands on research by Janda et al. [7], demonstrating 
that some patients felt totally dependent on their carers, while others tried to maintain 
independence. The legal requirement to cease driving on diagnosis inflicts dependence even on 
those who remain physically or cognitively intact in the early treatment stages. The loss of 
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control over many aspects of their lives was raised by those interviewed with many struggling to 
maintain their independence and continue in their daily activities.  Their ability to maintain 
control was further eroded with the uncertainty of the disease trajectory.
Continuity of communication with health professionals was essential for obtaining information 
and support. Patients highlighted the importance of being able to discuss issues with the treating 
doctor and their need to have someone they could contact when necessary. Several patients 
commented on the importance of keeping their general practitioner in the loop. Previous studies 
[7, 19] have similarly reported that patients would find it beneficial to have a readily available 
designated contact person. Health services need to be mindful of the importance that these key 
roles play in addressing patients’ needs.
The current study was informed by Zalenski and Raspa’s [13] adaption of Maslow’s hierarchy of 
needs [12]. Consistent with this adaption our participants experienced distressing symptoms and 
had needs in terms of restoring their lives.  After receiving their diagnosis patients feared 
experiencing debilitating symptoms, and were aware of the possibility of death. Patients were 
dependent on their carers, while carers provided physical and emotional support, reaffirming their 
love and support of the patient. Patients reflected back on their experiences, and some were able 
to frame their diagnosis positively because they were able to reassess and reconstruct their future 
personal goals and relationships to maintain an acceptable level of physical and psychological 
integrity. Finally, patients worked through their feelings about the prognosis they had been given 
and started to come to an acceptance of the possibility of their death.
4.1.1 Limitations 
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Participants were recruited from a single site; however, this site treats most neurological cancers 
from a population of approximately 1.5 million people. Nevertheless, data saturation was 
achieved by continuing data collection until no new themes emerged to describe the information 
and support needs of patients diagnosed with HGG. The inclusion of participants at different time 
points following diagnosis ensured a more complete understanding of patient’s needs, as did 
purposive sampling of patients with differing clinical and social situations. The prescence of a 
carer during some of the patient interviews may have limited the patients’ responses; 
however, this was unavoidable for this group of participants with the carer needing to be 
present to assist when the patient had physical limitations. While data collection at three time 
points was informative, further longitudinal research is required to determine how individual 
patient’s needs change over time and as they progress through treatment.  Future research by the 
authors will use quantitative methods to ascertain these needs. 
4.2 Conclusion
This study provides health professionals with an understanding of the information and support 
needs of patients living with HGG. The data suggest that patients were shocked, uncertain about 
the future, could not get a clear prognosis, did not know how their disease would progress or how 
to make plans. However, not all patients had these experiences, and some patients did not want to 
know about their disease in detail. Other concerns such as weight gain, seizures, visual and 
speech deficits, and inability to drive are more unique to patients with brain cancer. Each of these 
concerns had an impact on the patient’s whole lives and limited their independence and quality of 
life. For each of the participants, carers played an essential role in assisting patients with decision 
making, managing their health and assisting them physically.
4.3 Practice Implications
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This study has identified the need to individualise information with awareness of cognitive, 
visual, communication and memory deficits. Early and ongoing concerns about seizures, loss of 
independence and communication difficulty are more particular to patients with brain tumours 
and differ from other patients with terminal malignancy. Carers therefore play an essential role 
from the time of diagnosis and also need to be involved in each step of the patient’s journey. 
4.4 Future directions
The authors are now conducting a longitudinal survey with a larger sample of patients and carers 
to better understand how these patients information, support and practical needs change as their 
disease progresses, and to determine what tailored interventions could be used to specifically 
meet the needs of patients diagnosed with HGG.
We confirm all patient/personal identifiers have been removed or disguised so the 
patient/person(s) described are not identifiable and cannot be identified through the details of the 
story.
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Figure 1: Interview Guide for patient interviews 
Introduction
 How did you feel when you were diagnosed?
 Do you feel that your role in the family has been affected by the diagnosis of brain cancer? If so, how?
 Do you perceive yourself and your life differently since your diagnosis? 
The experience of making decisions
 What treatment have you received so far?
 Have you felt involved in making decisions about your treatment? How much have you been involved?
 How have you been involved in making decisions? 
 How satisfied are you with your level of involvement in making decisions? Why?
 Are you concerned about anything? If so what is/are your major concerns?
Information Needs
 Overall, what sort of information have you found most useful? Why was this?
 Can you identify what information has helped you to reduce your fears and/or concerns during 
consultations? What sort of information was most useful initially?
 So far, who has provided you with information? 
Info on Diagnosis
 What information have you been provided with about brain cancer?
 How prepared do you feel for what is likely to happen in the future? What information has helped you to 
feel prepared?
Info on Treatment
 What information has been provided about treatment so far? Prompts - Was this information helpful? 
 How do you feel about receiving treatment? Do you feel well informed at the moment? Are you concerned 
about anything? 
Info on Prognosis
 What information about prognosis has been provided? Was this information helpful? Why/why not? 
 Do you feel that you were told the right amount of information about prognosis? Too much? Too little? 
 Did you feel the timing of this information was appropriate?
 How much of this information do/did you understand?
Info in general
 What other information needs do you have? Is there anything you feel you don’t understand? 
 Have you read the written information that the doctors have given you? Has this been useful? In what way?
 Have you looked for/found additional information? What about? Where? When? Why?
 Which information sources have you found most useful/beneficial? – written, verbal, on line, videos. Why?
 Would you have preferred information to have been provided to you in a different way or using a different 
type of media? 
 When was information provided to you? Did you feel the timing was appropriate? Would you have 
preferred to receive information earlier/later?
 Have you had to ask for any information at a particular time? What sort?
Emotional and Practical Support Needs
 Can you identify who has provided you with support since your diagnosis? What sort of support have they 
provided you with? How has this been helpful?
 What (if any) practical supports do you currently need in your home? 
 What sorts of activities have you required support for recently?
 Can you identify any additional practical supports you may need in the future? (prompts-mobility aids, 
hygiene assistance, bathroom/house access, increasing levels of supervision, etc.)
 Can you identify who will provide these supports?
 So far, have you accessed support from sources outside of the hospital? If so, what? Did you find these 
sources helpful? Why/Why not?
 What has been the impact of being unable to drive on your life? What transport supports do you need?
Figure
Figure 1: Themes and Sub Themes for HGG patients
Feelings of uncertainty
- Uncertainty about prognosis 
- Uncertainty about how the diagnosis would affect 
their quality of life   
- Uncertainty about the side effects of treatment
The need for information 
- The need for information relating to prognosis
- The need for information to be provided using 
different types of medium
Dependence on their carer
- Managing weight gain
- Managing medication
- Loss of balance
- Inability to drive
Communication with health professionals
- Involvement in decision-making
- Opportunities to communicate and ask questions





















Table 1: Patient demographics
Frequency
Diagnosis Gioblastoma multiforme 
Grade IV
16
Astrocytoma Grade IV 1





Marital Status Married 18
Divorced 1





First Language English 18
Italian 1






















Leave without pay 4
Disability pension 3
Table
